Cancers Expressing HER-2 and/or CEA
1 clinical trials · Condition
◉ Watch Cancers Expressing HER-2 and/or CEA
| Record | Firm | Date |
|---|---|---|
| V930 First in Man (FIM) Study (V930-002)(COMPLETED) (NCT00250419) | Merck Sharp & Dohme LLC | 2005-09-01 |
Track Cancers Expressing HER-2 and/or CEA automatically
Every clearance here is in the API, with alerts when new ones post.